Indicator Amino Acid Oxidation in ICU Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Critical IllnessMuscle Wasting
Interventions
COMBINATION_PRODUCT

Standard protein enteral nutrition with enteral tracer

Enteral nutrition with standard (1.3 g/kg/d) protein provision, given via a nasogastric tube. An oral L-\[1-13C\]-phenylalanine tracer is given as co-intervention. Use of an enterally given tracer is necessary to determine indicator amino acid oxidation.

COMBINATION_PRODUCT

High protein enteral nutrition with enteral tracer

Enteral nutrition with high (2.0 g/kg/d) protein provision, given via a nasogastric tube. An oral L-\[1-13C\]-phenylalanine tracer is given as co-intervention. Use of an enterally given tracer is necessary to determine indicator amino acid oxidation.

Trial Locations (1)

6229 HX

Maastricht University Medical Center+, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT06104527 - Indicator Amino Acid Oxidation in ICU Patients | Biotech Hunter | Biotech Hunter